Static Chart Monte Rosa Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX 02:42:23 17/10/26 am AEDT			5-day change	1st Jan Change
9.965 ^USD	-1.53%		-3.79%	-36.80%

13/10	UBS Adjusts Price Target on Monte Rosa Therapeutics to $19 From $17, Maintains Buy Rating	MT
02/10	Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102	CI

Duration

Period